Segment and Geographic Information (Tables)

3 Months Ended

Jul. 31, 2020

Segment Reporting [Abstract]

Income From Operations Before Income Taxes by Reportable Segment and Reconciliation to Consolidated

The following tables present reconciliations of financial information from the segments to the applicable line items in the Company's consolidated financial statements:

Segment Operating Profit

	Three months ended
(in millions)	July 31, 2020		July 26, 2019
Cardiac and Vascular Group	$	759	$	1,055
Minimally Invasive Therapies Group	455		771
Restorative Therapies Group	523		793
Diabetes Group	103		149
Segment operating profit	1,840		2,768
Interest expense	(171)		(609)
Other non-operating income, net	82		101
Amortization of intangible assets	(440)		(440)
Corporate	(365)		(307)
Centralized distribution costs	(399)		(345)
Restructuring and associated costs	(128)		(124)
Acquisition-related items	105		(19)
Certain litigation charges, net	88		(47)
IPR&D charges	(10)		—
Debt tender premium and other charges	—		7
Medical device regulations	(18)		(8)
Income before income taxes	$	584	$	977

Net Sales to External Customers by Geography

The following table presents net sales for the three months ended July 31, 2020 and July 26, 2019 for the Company's country of domicile, countries with significant concentrations, and all other countries: 

	Three months ended
(in millions)	July 31, 2020		July 26, 2019
Ireland	$	24	$	20
United States	3,351		3,918
Rest of world	3,132		3,555
Total other countries, excluding Ireland	6,483		7,473
Total	$	6,507	$	7,493